Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011

Date: February 1, 2011
Pages: 75
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OF97BD9771AEN
Leaflet:

Download PDF Leaflet

Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, “Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011" provides data on the Other Central Nervous System Disorders clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Other Central Nervous System Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Brain Infarction . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
List of Tables
List of Figures
Introduction
Other Central Nervous System Disorders
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Other Central Nervous System Disorders
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Other Central Nervous System Disorders Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Sanofi-Aventis
Clinical Trial Overview of Sanofi-Aventis
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
Novartis AG
Clinical Trial Overview of Novartis AG
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Shire Plc
Clinical Trial Overview of Shire Plc
Biogen Idec Inc.
Clinical Trial Overview of Biogen Idec Inc.
Hospira, Inc.
Clinical Trial Overview of Hospira, Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Forest Laboratories, Inc.
Clinical Trial Overview of Forest Laboratories, Inc.
Air Liquide Sante International
Clinical Trial Overview of Air Liquide Sante International
EnVivo Pharmaceuticals
Clinical Trial Overview of EnVivo Pharmaceuticals
St. Michael's Hospital
Clinical Trial Overview of St. Michael's Hospital
Spectrum Health System
Clinical Trial Overview of Spectrum Health System
Clarian Health Partners, Inc.
Clinical Trial Overview of Clarian Health Partners, Inc.
Neuro Diagnostic Devices
Clinical Trial Overview of Neuro Diagnostic Devices
Bracco S.p.A.
Clinical Trial Overview of Bracco S.p.A.
ZARS Pharma, Inc.
Clinical Trial Overview of ZARS Pharma, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Institute of Mental Health (NIMH)
Clinical Trial Overview of National Institute of Mental Health (NIMH)
National Institute on Drug Abuse
Clinical Trial Overview of National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Neurological Disorders and Stroke
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
Vanderbilt University
Clinical Trial Overview of Vanderbilt University
Norwegian University of Science and Technology
Clinical Trial Overview of Norwegian University of Science and Technology
Nantes University Hospital
Clinical Trial Overview of Nantes University Hospital
Yale University
Clinical Trial Overview of Yale University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
Oregon Health and Science University
Clinical Trial Overview of Oregon Health and Science University
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital

APPENDIX

Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Zone, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, North America, Top Countries, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, BRIC Countries, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Phase, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Suspended Clinical Trials, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Withdrawn Clinical Trials, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Terminated Clinical Trials, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011**
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospira, Inc., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Air Liquide Sante International, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by EnVivo Pharmaceuticals, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Michael's Hospital, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Health System, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Clarian Health Partners, Inc., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuro Diagnostic Devices, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Bracco S.p.A., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by ZARS Pharma, Inc., 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health (NIMH), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011*

LIST OF FIGURES

Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, BRIC Countries (%), 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
Other Central Nervous System Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
Other Central Nervous System Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
GlobalData Methodology 73

Ask Your Question

Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: